Cousin vs. Sibling Donors in Haplo-HSCT

Starting soon

Conditions studied: Hematopoietic Malignancies, Haploidentical Hematopoietic Stem Cell Transplantation, Donor

In brief

This observational study aims to emulate a hypothetical pragmatic, multicenter, non-blinded clinical trial enrolling adult patients undergoing haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with grafts derived from either cousin or sibiling donors. The main research question is whether cousin donor-derived haplo-HSCT is associated with inferior clinical outcomes relative to sibling donor-derived haplo-HSCT. Study participants consist of adult patients diagnosed with hematological malignancies who underwent cousin or sibiling haplo-HSCT between 2017 and 2024, and all eligible recipients will receive regular follow-up assessments.

Key facts

Study ID
NCT07662382
Run by
The First Affiliated Hospital of Soochow University
People needed
1000
Starts
2026-08-01
Expected to finish
2027-10-31
Last updated by the study team
2026-06-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.